Slingshot members are tracking this event:
Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jun 09, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Nda, Linaclotide, Chronic Idiopathic Constipation, Cic